India's Pharmaceutical Exports

Country Profile

Afghanistan

Afghanistan is a growing market for Indian pharmaceuticals — $114M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $30.1M. The compound annual growth rate since FY2015 stands at 10.7%.

🇦🇫 $114M · 3.1× growth since FY2015 · 10.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$114M
Exports FY2025–26 DGCIS
3.1×
Growth FY2015→2026
10.7%
CAGR FY2015→2026
68%
Medicines Share
5
Product Categories Supplied
Afghanistan is a growing market for Indian pharmaceuticals — $114M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $30.1M. The compound annual growth rate since FY2015 stands at 10.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $77.6M (68.4%) Vaccines $30.1M (26.5%) Medicine Ingredients $3.53M (3.1%) Traditional & Herbal $1.22M (1.1%) Surgical & Hospital Supplies $1.08M (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Afghanistan in the RBI overseas direct investment dataset (2011–2026).